Diseases, Conditions, Syndromes

Biden team says US will not lift travel bans, despite Trump statement

US President-elect Joe Biden's spokeswoman quickly dismissed Donald Trump's announcement Monday that a COVID-19 ban on travelers arriving from much of Europe and Brazil would be lifted, underlining the fractious transition ...

Diseases, Conditions, Syndromes

Arizona deemed 'hot spot of the world' amid virus surge

Five months after President Donald Trump hailed Arizona as a model for how it dealt with the COVID-19 pandemic, public health experts warned Wednesday that the state has become "the hot spot of the world" and that health ...

Diseases, Conditions, Syndromes

Fauci: Vaccinations are increasing in a 'glimmer of hope'

The U.S. ramped up COVID-19 vaccinations in the past few days after a slower-than-expected start, bringing the number of shots dispensed to about 4 million, government health officials said Sunday.

Medical economics

Support for Obamacare grows as Biden takes control: Poll

(HealthDay)—The popularity of the Affordable Care Act, or Obamacare, continues to grow, with nearly two-thirds of Americans saying they want the law to remain as is or be improved, a new Harris/HealthDay poll shows.

Medical research

Messenger RNA: How a long shot idea led to COVID-19 vaccines

Hungarian-born scientist Katalin Kariko's obsession with researching a substance called mRNA to fight disease once cost her a faculty position at a prestigious US university, which dismissed the idea as a dead end.

Vaccination

Behind in vaccine race, CureVac bets on 'easier' jab

CureVac CEO Franz-Werner Haas readily admits his German biotech firm is "a bit behind" in the COVID-19 vaccine race, despite using the same cutting-edge technology as rivals Moderna and Pfizer/BioNTech.

page 11 from 40